Rossari Biotech share price
You have to be logged in to add this to Watchlist.- ₹685.80(-0.25%)April 17, 2025 15:29:43 PM IST
- NSE
- BSE
- Vol : 27.64K (NSE + BSE)Last 20 day avg : 85.47 K
Rossari Biotech is trading -0.25% lower at Rs 685.80 as compared to its last closing price. Rossari Biotech has been trading in the price range of 688.60 & 677.00. Rossari Biotech has given -12.38% in this year & 6.80% in the last 5 days. Rossari Biotech has TTM P/E ratio 31.57 as compared to the sector P/E of 17.95.There are 5 analysts who have initiated coverage on Rossari Biotech. There are 4 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 31.70 Crores in its last quarter.Listed peers of Rossari Biotech include Grauer & Weil (india) (1.79%), Nacl Industries (5.00%), Rossari Biotech (-0.25%).The Mutual Fund holding in Rossari Biotech was at 13.25% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Rossari Biotech was at 3.74% in 31 Dec 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 19, 2025, 02:01 PM UTC
- Dividend YieldLower than industry0.07Annual dividends as a percentage of the stock price.
- P/BLower than historical values3.59The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values27.72Price-to-earnings ratio based on trailing 12-month earnings
- BetaMedium volatility1.11Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.11The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 10.56% from Rs 512.73 crore to Rs 463.77 crore, year-on-year
The company's profit declined by 7.82% year-on-year during the December quarter, dropping from Rs 34.39 crore to Rs 31.70 crore- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 671.35
- R2
- 738.65
- R3
- 780.30
- S1
- 562.40
- S2
- 520.75
- S3
- 453.45
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Grauer & Weil (india) | Moderately Bearish | 85.82 | 1.79 | 3,891.18 | 26.62 | 4.83 | 0.58 | 0.68 |
| Nacl Industries | Bullish | 190.20 | 5.00 | 3,793.33 | - | 7.39 | - | 29.23 |
| Rossari Biotech | Neutral | 685.80 | -0.25 | 3,796.85 | 29.14 | 3.59 | 0.07 | 4.22 |
| Bhagiradha Chemicals & Industri | Moderately Bearish | 284.55 | -0.94 | 3,689.73 | 177.22 | 7.16 | 0.04 | 4.15 |
| Kiri Industries | Bullish | 641.80 | -0.13 | 3,570.27 | 25.01 | 1.18 | - | 0.85 |
- Promoter(s) holds a high stake in the company at 68.19%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding is constant over the last quarter at 3.74%
- Mutual Funds holding has increased by 0.07 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-01-21 | Quarterly Results |
| 2024-10-19 | Quarterly Results |
| 2024-07-20 | Quarterly Results |
| 2024-04-29 | Audited Results & Final Dividend |
| 2024-01-20 | Quarterly Results |
- IndustryChemical Manufacturing
- ISININE02A801020
- BSE Code543213
- NSE CodeROSSARI
Rossari Biotech is trading at 685.80 as on Thu Apr 17 2025 09:59:43. This is -0.25% lower as compared to its previous closing price of 687.55.
The market capitalization of Rossari Biotech is 3796.85 Cr as on Thu Apr 17 2025 09:59:43.
The average broker rating on Rossari Biotech is Strong Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Rossari Biotech is 966.00 whereas the 52 wk low is 568.05
Rossari Biotech can be analyzed on the following key metrics -
- TTM P/E: 31.57
- Sector P/E: 17.95
- Dividend Yield: 0.07%
- D/E ratio: -
Rossari Biotech reported a net profit of 130.69 Cr in 2024.
The Mutual Fund Shareholding was 13.25% at the end of 31 Dec 2024.